Total Funding
26
Total FundingPost-IPO Debt raised
Growth Score
pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
124702
Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men.
- Ann Tomlin: Senior Vice President Human Resources
- Steven Egge: VP and General Manager
Sumitovant
About the Company
Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. The company's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and women’s health.
Myovant Sciences was established in 2016 and is based in Brisbane,
California.
